Axon Neuroscience’s active tau immunotherapy, AADvac1, has been selected as the first tau-targeted therapy to enter a ...

Axon has long served law enforcement agencies, but it's expanding into new markets. The company has almost tripled its net income in the last three years. Management estimates its total addressable ...

After accusing Flock of coercive behavior and trying to lock police into its products, Axon tries to eat its ex-partner’s lunch. It’s announced new AI and drone tech too. America’s biggest police tech ...

Shares of self defense company AXON (NASDAQ:AXON) jumped 7.1% in the afternoon session after Northcoast Research upgraded the stock to buy from neutral. The firm also set a price target of $742 for ...